These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Lamellar cytoplasmic inclusions in the collecting tubules of the kidney in the course of osmotic nephrosis. Electron microscopical study]. Melis M; Orci L Z Zellforsch Mikrosk Anat; 1967; 77(3):425-34. PubMed ID: 5598323 [No Abstract] [Full Text] [Related]
49. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055 [TBL] [Abstract][Full Text] [Related]
50. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention]. Fakhouri F Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831 [TBL] [Abstract][Full Text] [Related]
51. Drinking and renal responses to peripherally administered osmotic stimuli in the pigeon (Columbia livia). Thornton SN J Physiol; 1984 Jun; 351():501-15. PubMed ID: 6431086 [TBL] [Abstract][Full Text] [Related]
52. Acute renal failure after intravenous immunoglobulin therapy. Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648 [TBL] [Abstract][Full Text] [Related]
53. Osmotic Nephrosis Induced by Water-Soluble Triiodinated Contrast Media in Man. A Retrospective Study of 47 Cases. Moreau JF; Droz D; Sabto J; Jungers P; Kleinknecht D; Hinglais N; Michel JR Radiology; 1975 May; 115(2):329-36. PubMed ID: 1096233 [TBL] [Abstract][Full Text] [Related]
54. [On nephrotic lesions caused by sucrose]. Corvilain J; Parmentier R Rev Belg Pathol Med Exp; 1956 Jul; 25(3):200-18. PubMed ID: 13379980 [No Abstract] [Full Text] [Related]
55. Not all intravenous immunoglobulin preparations are equally well tolerated. Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625 [TBL] [Abstract][Full Text] [Related]
56. Case report: acute renal failure after administering intravenous immunoglobulin. Graumann A; Zawada ET Postgrad Med; 2010 Mar; 122(2):142-7. PubMed ID: 20203465 [TBL] [Abstract][Full Text] [Related]
57. Nephrotoxicity related to new therapeutic compounds. Szeto CC; Chow KM Ren Fail; 2005; 27(3):329-33. PubMed ID: 15957551 [TBL] [Abstract][Full Text] [Related]
58. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Sekul EA; Cupler EJ; Dalakas MC Ann Intern Med; 1994 Aug; 121(4):259-62. PubMed ID: 8037406 [TBL] [Abstract][Full Text] [Related]
59. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study. Onuigbo MA Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):320-2. PubMed ID: 22238243 [No Abstract] [Full Text] [Related]
60. Ochratoxin A and citrinin induced nephrosis in Beagle dogs. III. Terminal renal ultrastructural alterations. Kitchen DN; Carlton WW; Hinsman EJ Vet Pathol; 1977 Jul; 14(4):392-406. PubMed ID: 560743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]